Boyar Asset Management Inc. Increases Stake in Kenvue Inc. (NYSE:KVUE)

Boyar Asset Management Inc. increased its holdings in Kenvue Inc. (NYSE:KVUE) by 2.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 29,876 shares of the company’s stock after acquiring an additional 705 shares during the quarter. Boyar Asset Management Inc.’s holdings in Kenvue were worth $638,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Handelsbanken Fonder AB boosted its stake in shares of Kenvue by 2.9% during the fourth quarter. Handelsbanken Fonder AB now owns 742,184 shares of the company’s stock valued at $15,846,000 after purchasing an additional 21,222 shares in the last quarter. Alberta Investment Management Corp lifted its holdings in Kenvue by 23.2% during the fourth quarter. Alberta Investment Management Corp now owns 582,895 shares of the company’s stock worth $12,445,000 after buying an additional 109,700 shares during the period. Longbow Finance SA boosted its position in Kenvue by 5.0% during the 4th quarter. Longbow Finance SA now owns 280,568 shares of the company’s stock valued at $5,990,000 after acquiring an additional 13,287 shares in the last quarter. Steward Partners Investment Advisory LLC increased its holdings in shares of Kenvue by 143.1% in the 4th quarter. Steward Partners Investment Advisory LLC now owns 47,938 shares of the company’s stock valued at $1,023,000 after acquiring an additional 28,216 shares during the period. Finally, CORDA Investment Management LLC. raised its position in shares of Kenvue by 1.4% in the 4th quarter. CORDA Investment Management LLC. now owns 1,253,096 shares of the company’s stock worth $26,754,000 after acquiring an additional 17,466 shares in the last quarter. 97.64% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on KVUE shares. Piper Sandler lifted their target price on Kenvue from $24.00 to $27.00 and gave the company an “overweight” rating in a research note on Monday, February 24th. Barclays cut their price objective on shares of Kenvue from $23.00 to $22.00 and set an “equal weight” rating on the stock in a research report on Monday, April 14th. Citigroup raised their target price on shares of Kenvue from $21.00 to $22.00 and gave the company a “neutral” rating in a research note on Monday, April 14th. Redburn Atlantic initiated coverage on Kenvue in a research report on Thursday, April 10th. They set a “neutral” rating and a $23.50 price target on the stock. Finally, Evercore ISI assumed coverage on Kenvue in a report on Monday, March 24th. They set an “in-line” rating and a $25.00 price objective for the company. Eight analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Kenvue has an average rating of “Hold” and a consensus target price of $24.42.

Kenvue Trading Up 1.3 %

Shares of NYSE:KVUE opened at $23.40 on Wednesday. The business has a 50-day moving average price of $23.06 and a 200-day moving average price of $22.46. The stock has a market cap of $44.90 billion, a price-to-earnings ratio of 44.15, a PEG ratio of 2.62 and a beta of 1.02. Kenvue Inc. has a 52-week low of $17.67 and a 52-week high of $24.46. The company has a quick ratio of 0.69, a current ratio of 1.00 and a debt-to-equity ratio of 0.66.

Kenvue (NYSE:KVUE) last posted its quarterly earnings results on Thursday, February 6th. The company reported $0.26 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.26. Kenvue had a net margin of 6.66% and a return on equity of 20.97%. Equities analysts predict that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 28th. Investors of record on Wednesday, May 14th will be given a dividend of $0.205 per share. This represents a $0.82 annualized dividend and a yield of 3.50%. The ex-dividend date of this dividend is Wednesday, May 14th. Kenvue’s dividend payout ratio is currently 154.72%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.